Stockholm Stock Exchange | Mid Cap
Camurus
+12.07%
Latest
+12.07%
3 months
DNB CarnegiePareto SecuritiesNordea MarketsJefferiesSEBDNB MarketsDNBBryan GarnierCarnegieHandelsbanken Capital MarketsJefferies InternationalHandelsbanken

About The Company

Camurus AB is a Swedish research-based pharmaceutical and biotechnology company specialising in the commercialization of medicines for treating serious and chronic diseases.
Wikipedia